FDA clears AI-enabled cardiac MR planning technology from Philips

March 7, 2026 - 11:13

A new artificial intelligence-driven technology designed to dramatically speed up cardiac magnetic resonance (MR) exam planning has been cleared by the U.S. Food and Drug Administration. The system automates the acquisition of 14 essential cardiac views in under half a minute, a process that traditionally requires extensive manual manipulation by a technologist.

This advancement aims to address key challenges in busy hospital imaging departments. By automating complex scan planning steps, the technology seeks to boost clinical productivity, allowing staff to focus more on patient care. Furthermore, it promises to bring greater standardization and consistency to cardiac MR exams, which can vary based on operator experience.

The rapid, AI-enabled planning is intended to make the sophisticated diagnostic power of cardiac MR more accessible and efficient. Consistent, high-quality image acquisition is fundamental for accurate diagnosis and monitoring of heart conditions, from heart failure to cardiomyopathies. This clearance marks a significant step toward integrating AI-assisted workflows into routine cardiac imaging, potentially improving both departmental workflow and diagnostic confidence.